These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19227610)

  • 21. Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals.
    Huhn AS; Strain EC; Bigelow GE; Smith MT; Edwards RR; Tompkins DA
    Anesthesiology; 2019 Jan; 130(1):131-141. PubMed ID: 30418214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of hydromorphone in acute and chronic pain.
    Quigley C; Wiffen P
    J Pain Symptom Manage; 2003 Feb; 25(2):169-78. PubMed ID: 12590032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydromorphone does not influence the immune response in patients affected by chronic pain.
    Coaccioli S; Di Cato L; Panaccione A; Crapa ME; Paladini A; Piroli A; Marinangeli F
    Clin Ter; 2013; 164(2):e97-9. PubMed ID: 23698222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pain therapy. Extensive possibilities not adequately utilized].
    MMW Fortschr Med; 2005 May; 147(19):60-1. PubMed ID: 15940943
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2008 Aug; 31(4):334-43. PubMed ID: 18638294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Opioids. Pharmacology, clinic, prospectives for an extensive use].
    Ginobbi P; Tirelli W; D'Angiolino G; Ciocca F; Centulio F; Pelagalli L; Marcelli ME; Arcuri E
    Recenti Prog Med; 2000 Dec; 91(12):621-7. PubMed ID: 11194479
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pain therapy in patients with tumors. According to graduated schedule and hourly plan].
    MMW Fortschr Med; 2003 Oct; 145(40):53. PubMed ID: 14603608
    [No Abstract]   [Full Text] [Related]  

  • 28. Opioid Pharmacokinetics-Pharmacodynamics: Clinical Implications in Acute Pain Management in Trauma.
    MacKenzie M; Zed PJ; Ensom MH
    Ann Pharmacother; 2016 Mar; 50(3):209-18. PubMed ID: 26739277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, randomized comparative study to investigate the morphine to hydromorphone conversion ratio in Japanese cancer patients.
    Inoue S; Saito Y; Tsuneto S; Aruga E; Ogata T; Uemori M
    Jpn J Clin Oncol; 2018 May; 48(5):442-449. PubMed ID: 29635632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of hydromorphone (Dilaudid) and morphine for patients with hepatic and renal impairment.
    Razaq M; Balicas M; Mankan N
    Am J Ther; 2007; 14(4):414-6. PubMed ID: 17667220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo studies of subcutaneous hydromorphone implants designed for the treatment of cancer pain.
    Lesser GJ; Grossman SA; Leong KW; Lo H; Eller S
    Pain; 1996; 65(2-3):265-72. PubMed ID: 8826516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palladone for chronic pain.
    Med Lett Drugs Ther; 2005 Mar; 47(1204):21-3. PubMed ID: 15767975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydromorphone use for acute pain: Misconceptions, controversies, and risks.
    Mazer-Amirshahi M; Motov S; Nelson LS
    J Opioid Manag; 2018; 14(1):61-71. PubMed ID: 29508897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidural analgesia compared with intravenous analgesia after pediatric posterior spinal fusion.
    Gauger VT; Voepel-Lewis TD; Burke CN; Kostrzewa AJ; Caird MS; Wagner DS; Farley FA
    J Pediatr Orthop; 2009 Sep; 29(6):588-93. PubMed ID: 19700988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of hydromorphone in cancer pain treatment: a systematic review.
    Pigni A; Brunelli C; Caraceni A
    Palliat Med; 2011 Jul; 25(5):471-7. PubMed ID: 21708853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Navigating clinical care at the intersection of pain and addiction.
    Krupnick SL
    Medsurg Nurs; 2009; 18(6):381-4. PubMed ID: 20088194
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental pharmacodynamics and analgesic efficacy of liposome-encapsulated hydromorphone in dogs.
    Krugner-Higby L; Smith L; Schmidt B; Wunsch L; Smetana A; Brown C; Heath TD
    J Am Anim Hosp Assoc; 2011; 47(3):185-95. PubMed ID: 21498589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment.
    Müssig K; Knaus-Dittmann D; Schmidt H; Mörike K; Häring HU
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):604-5. PubMed ID: 17371484
    [No Abstract]   [Full Text] [Related]  

  • 39. Randomized clinical trial comparing a patient-driven titration protocol of intravenous hydromorphone with traditional physician-driven management of emergency department patients with acute severe pain.
    Chang AK; Bijur PE; Davitt M; Gallagher EJ
    Ann Emerg Med; 2009 Oct; 54(4):561-567.e2. PubMed ID: 19560838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Observational data in elderly pain patients show that fear of opioid therapy is unfounded].
    Junker U; Figge V
    MMW Fortschr Med; 2005 Jul; 147(27-28):43. PubMed ID: 16041941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.